Re-assessing the risks of drug-induced arrhythmias during drug discovery
Drug Discovery World
AUGUST 15, 2023
However, development pipelines across multiple therapeutic areas are still not meeting the anticipated clinical outcomes that are needed for bringing new and cost-effective drugs to patients. Unexpected late-stage failures in drug development are, of course, the costliest. 2012) Nature Reviews Drug Discovery, 11: 191–200.
130 
Let's personalize your content